… regulatory landscape, the physico-chemical and biological  characterisation of viral vector-based products is … designed to instruct patients’ own cells to produce a protein that can treat, cure or prevent diseases. mRNA … infectious diseases, as cancer immunotherapy, and as protein replacement therapy for rare diseases. Building on …

… to  accelerate therapeutics drugs such as mAbs, vaccines, cell therapy and novel products  … to support your developments of  mAbs , ADCs and proteins . Vaccines Whatever the type of antigen,  Quality Assistance …

… services Bioanalytical services Elemental impurities Characterisation of proteins by MS PRODUCT-DEDICATED EXPERTISE Monoclonal … needed to support  vaccine  development, including product characterisation, development and validation of analytical …